Aktive Positionen von Richard W. Frazee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Technik-/Wissenschafts-/F&E-Leiter | 20.09.2011 | - |
| Gründer | 20.09.2011 | - |
Karriereverlauf von Richard W. Frazee
Ehemalige bekannte Positionen von Richard W. Frazee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Michigan | Corporate Officer/Principal | - | - |
| The Johns Hopkins University | Corporate Officer/Principal | - | - |
| Rowan University | Corporate Officer/Principal | - | - |
Ausbildung von Richard W. Frazee
| University of Minnesota | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
- Börse
- Insiders
- Richard W. Frazee
- Erfahrung
